Editorial: Big data shaping clinical trial landscape—Greater role for pharmacoeconomics in Asia

Jakovljević, Mihajlo

doi:10.3389/fpubh.2022.1037082

Cited by 2 publications

(1 citation statement)

References 9 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Furthermore, the APAC region has been identified as the fastest-growing destination for medical device clinical trials, with China and Japan considered the top clinical trial hotspots 25 . The APAC region has also been positioned as the second largest market for medical devices 26 . Accordingly, it is essential to upgrade the capacity of the research organisations in the APAC region, to increase their independence and sustainability in clinical research.…”

Section: Discussionmentioning

confidence: 99%

Variability in research culture across busy catheterisation labs in the Asia-Pacific region

Narang,

Saxena,

Kaur

et al. 2024

AsiaIntervention

View full text Add to dashboard Cite

Background: Information related to research culture in the busy catheterisation (cath) labs across the Asia-Pacific (APAC) region is sparse. Aims:The aims of this study were to examine the variability in research culture in busy cath labs in the APAC region and to propose a roadmap for hospitals to develop in-house research capabilities in conjunction with industry and academia.Methods: Data related to research practices in the APAC region were collected from busy cath labs (at least 250 angioplasty/year) and analysed. Results were shared with research experts to understand the challenges in institutional research and create a roadmap for hospitals to develop research capabilities.Results: A total of 220 respondents from 62 cath labs (88.6%) across 13 APAC countries participated in the survey. A wide variation was noted in research culture across APAC countries. Well-established infrastructure was reported in Australia, New Zealand, South Korea, Singapore, and Japan. Large multicentre trials were common in South Korea, while routine follow-ups were common in Japan. Linking medical records across hospitals/states was considered challenging. Research exposure and training were limited in the APAC region. The experts suggested a roadmap, including creating a conducive regulatory environment, forming synergistic goals, training programs for the professionals involved in research, and leveraging best practices, for improving the research culture in APAC.Conclusions: Clinical research in cardiology has grown significantly in the APAC region, with a huge research potential in China and India. Implementing measures to improve research training and involvement of the industry will boost the research culture in the APAC region.

show abstract

Section: Discussionmentioning

confidence: 99%